RADNET INC (RDNT) Stock Fundamental Analysis
NASDAQ:RDNT - US7504911022 - Common Stock
72.165 USD
+0.38 (+0.52%)
Taking everything into account, RDNT scores 4 out of 10 in our fundamental rating. RDNT was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of RDNT get a neutral evaluation. Nothing too spectacular is happening here. RDNT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
RDNT had positive earnings in the past year.
RDNT had a positive operating cash flow in the past year.
Of the past 5 years RDNT 4 years were profitable.
Each year in the past 5 years RDNT had a positive operating cash flow.
1.2 Ratios
The Return On Assets of RDNT (-0.42%) is comparable to the rest of the industry.
The Return On Equity of RDNT (-1.60%) is comparable to the rest of the industry.
RDNT has a Return On Invested Capital (2.21%) which is in line with its industry peers.
RDNT had an Average Return On Invested Capital over the past 3 years of 2.96%. This is significantly below the industry average of 9.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.42% | ||
| ROE | -1.6% | ||
| ROIC | 2.21% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
RDNT's Profit Margin has declined in the last couple of years.
The Operating Margin of RDNT (4.17%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
RDNT has a Gross Margin (22.67%) which is comparable to the rest of the industry.
RDNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.17% | ||
| PM (TTM) | N/A | ||
| GM | 22.67% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RDNT is destroying value.
RDNT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for RDNT has been increased compared to 5 years ago.
The debt/assets ratio for RDNT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.05 indicates that RDNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
RDNT has a Altman-Z score of 2.05. This is comparable to the rest of the industry: RDNT outperforms 50.49% of its industry peers.
RDNT has a debt to FCF ratio of 14.51. This is a negative value and a sign of low solvency as RDNT would need 14.51 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 14.51, RDNT is in line with its industry, outperforming 44.55% of the companies in the same industry.
RDNT has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RDNT (1.16) is worse than 63.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 2.05 |
ROIC/WACC0.25
WACC8.81%
2.3 Liquidity
A Current Ratio of 2.00 indicates that RDNT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.00, RDNT is in the better half of the industry, outperforming 74.26% of the companies in the same industry.
RDNT has a Quick Ratio of 2.00. This indicates that RDNT is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of RDNT (2.00) is better than 77.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2 | ||
| Quick Ratio | 2 |
3. Growth
3.1 Past
RDNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.84%.
RDNT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.79% yearly.
Looking at the last year, RDNT shows a quite strong growth in Revenue. The Revenue has grown by 11.32% in the last year.
The Revenue has been growing by 9.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-36.84%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%93.75%
Revenue 1Y (TTM)11.32%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%8.38%
3.2 Future
The Earnings Per Share is expected to grow by 33.51% on average over the next years. This is a very strong growth
Based on estimates for the next years, RDNT will show a quite strong growth in Revenue. The Revenue will grow by 8.21% on average per year.
EPS Next Y-42.64%
EPS Next 2Y16.04%
EPS Next 3Y33.51%
EPS Next 5YN/A
Revenue Next Year8.47%
Revenue Next 2Y8.29%
Revenue Next 3Y8.21%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 200.46, which means the current valuation is very expensive for RDNT.
RDNT's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of RDNT to the average of the S&P500 Index (27.17), we can say RDNT is valued expensively.
With a Price/Forward Earnings ratio of 85.07, RDNT can be considered very expensive at the moment.
60.40% of the companies in the same industry are cheaper than RDNT, based on the Price/Forward Earnings ratio.
RDNT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 200.46 | ||
| Fwd PE | 85.07 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as RDNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 73.03 | ||
| EV/EBITDA | 20.54 |
4.3 Compensation for Growth
A more expensive valuation may be justified as RDNT's earnings are expected to grow with 33.51% in the coming years.
PEG (NY)N/A
PEG (5Y)11.94
EPS Next 2Y16.04%
EPS Next 3Y33.51%
5. Dividend
5.1 Amount
RDNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:RDNT (8/29/2025, 9:51:44 AM)
72.165
+0.38 (+0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.32%
Inst Owner Change1.24%
Ins Owners13.16%
Ins Owner Change-1.94%
Market Cap5.55B
Analysts86.15
Price Target75.19 (4.19%)
Short Float %9.53%
Short Ratio8.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-33.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)93.99%
EPS beat(4)3
Avg EPS beat(4)-10.19%
Min EPS beat(4)-161.6%
Max EPS beat(4)93.99%
EPS beat(8)6
Avg EPS beat(8)171.54%
EPS beat(12)7
Avg EPS beat(12)120.14%
EPS beat(16)9
Avg EPS beat(16)-188.91%
Revenue beat(2)1
Avg Revenue beat(2)2.08%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)4.27%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.11%
Max Revenue beat(4)4.27%
Revenue beat(8)7
Avg Revenue beat(8)1.62%
Revenue beat(12)10
Avg Revenue beat(12)2.01%
Revenue beat(16)11
Avg Revenue beat(16)0.91%
PT rev (1m)2.99%
PT rev (3m)2.86%
EPS NQ rev (1m)12.4%
EPS NQ rev (3m)16.84%
EPS NY rev (1m)53.09%
EPS NY rev (3m)10.95%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)1.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 200.46 | ||
| Fwd PE | 85.07 | ||
| P/S | 2.91 | ||
| P/FCF | 73.03 | ||
| P/OCF | 21.21 | ||
| P/B | 5.95 | ||
| P/tB | 61.87 | ||
| EV/EBITDA | 20.54 |
EPS(TTM)0.36
EY0.5%
EPS(NY)0.85
Fwd EY1.18%
FCF(TTM)0.99
FCFY1.37%
OCF(TTM)3.4
OCFY4.72%
SpS24.8
BVpS12.12
TBVpS1.17
PEG (NY)N/A
PEG (5Y)11.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.42% | ||
| ROE | -1.6% | ||
| ROCE | 2.68% | ||
| ROIC | 2.21% | ||
| ROICexc | 3.07% | ||
| ROICexgc | 5.07% | ||
| OM | 4.17% | ||
| PM (TTM) | N/A | ||
| GM | 22.67% | ||
| FCFM | 3.98% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score4
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.16 | ||
| Debt/FCF | 14.51 | ||
| Debt/EBITDA | 3.82 | ||
| Cap/Depr | 91.79% | ||
| Cap/Sales | 9.74% | ||
| Interest Coverage | 0.93 | ||
| Cash Conversion | 92.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2 | ||
| Quick Ratio | 2 | ||
| Altman-Z | 2.05 |
F-Score4
WACC8.81%
ROIC/WACC0.25
Cap/Depr(3y)97.03%
Cap/Depr(5y)109.5%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.84%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%93.75%
EPS Next Y-42.64%
EPS Next 2Y16.04%
EPS Next 3Y33.51%
EPS Next 5YN/A
Revenue 1Y (TTM)11.32%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%8.38%
Revenue Next Year8.47%
Revenue Next 2Y8.29%
Revenue Next 3Y8.21%
Revenue Next 5YN/A
EBIT growth 1Y-27.98%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year110.31%
EBIT Next 3Y38.68%
EBIT Next 5YN/A
FCF growth 1Y93.91%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.3%
OCF growth 3Y15.95%
OCF growth 5Y17.44%